BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 26827767)

  • 1. Resveratrol augments therapeutic efficiency of mouse bone marrow mesenchymal stem cell-based therapy in experimental autoimmune encephalomyelitis.
    Wang D; Li SP; Fu JS; Bai L; Guo L
    Int J Dev Neurosci; 2016 Apr; 49():60-6. PubMed ID: 26827767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effective combination of human bone marrow mesenchymal stem cells and minocycline in experimental autoimmune encephalomyelitis mice.
    Hou Y; Ryu CH; Park KY; Kim SM; Jeong CH; Jeun SS
    Stem Cell Res Ther; 2013 Jul; 4(4):77. PubMed ID: 23826999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased severity of experimental autoimmune encephalomyelitis during resveratrol administration is associated with increased IL-17+IL-10+ T cells, CD4(-) IFN-gamma+ cells, and decreased macrophage IL-6 expression.
    Imler TJ; Petro TM
    Int Immunopharmacol; 2009 Jan; 9(1):134-43. PubMed ID: 19022403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapamycin Augments Immunomodulatory Properties of Bone Marrow-Derived Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis.
    Togha M; Jahanshahi M; Alizadeh L; Jahromi SR; Vakilzadeh G; Alipour B; Gorji A; Ghaemi A
    Mol Neurobiol; 2017 May; 54(4):2445-2457. PubMed ID: 26971291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human mesenchymal stem cells upregulate CD1dCD5(+) regulatory B cells in experimental autoimmune encephalomyelitis.
    Guo Y; Chan KH; Lai WH; Siu CW; Kwan SC; Tse HF; Wing-Lok Ho P; Wing-Man Ho J
    Neuroimmunomodulation; 2013; 20(5):294-303. PubMed ID: 23899693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. β-Lapachone ameliorization of experimental autoimmune encephalomyelitis.
    Xu J; Wagoner G; Douglas JC; Drew PD
    J Neuroimmunol; 2013 Jan; 254(1-2):46-54. PubMed ID: 23010281
    [TBL] [Abstract][Full Text] [Related]  

  • 7. G-CSF treatment promotes apoptosis of autoreactive T cells to restrict the inflammatory cascade and accelerate recovery in experimental allergic encephalomyelitis.
    Peng W
    Exp Neurol; 2017 Mar; 289():73-84. PubMed ID: 27771353
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection from experimental autoimmune encephalomyelitis by polyclonal IgG requires adjuvant-induced inflammation.
    Quast I; Keller CW; Weber P; Schneider C; von Gunten S; Lünemann JD
    J Neuroinflammation; 2016 Feb; 13():42. PubMed ID: 26893156
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytokine production profiles in chronic relapsing-remitting experimental autoimmune encephalomyelitis: IFN-γ and TNF-α are important participants in the first attack but not in the relapse.
    Hidaka Y; Inaba Y; Matsuda K; Itoh M; Kaneyama T; Nakazawa Y; Koh CS; Ichikawa M
    J Neurol Sci; 2014 May; 340(1-2):117-22. PubMed ID: 24655735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of CNTF in Mesenchymal Stem Cells reduces demyelination and induces clinical recovery in experimental autoimmune encephalomyelitis mice.
    Lu Z; Hu X; Zhu C; Wang D; Zheng X; Liu Q
    J Neuroimmunol; 2009 Jan; 206(1-2):58-69. PubMed ID: 19081144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic and Superimposed Effect of Bone Marrow-Derived Mesenchymal Stem Cells Combined with Fasudil in Experimental Autoimmune Encephalomyelitis.
    Yu JW; Li YH; Song GB; Yu JZ; Liu CY; Liu JC; Zhang HF; Yang WF; Wang Q; Yan YP; Xiao BG; Ma CG
    J Mol Neurosci; 2016 Dec; 60(4):486-497. PubMed ID: 27573128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes.
    Berghmans N; Heremans H; Li S; Martens E; Matthys P; Sorokin L; Van Damme J; Opdenakker G
    J Neuroinflammation; 2012 Oct; 9():243. PubMed ID: 23095573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gold nanoparticles and polyethylene glycol alleviate clinical symptoms and alter cytokine secretion in a mouse model of experimental autoimmune encephalomyelitis.
    Aghaie T; Jazayeri MH; Avan A; Anissian A; Salari AA
    IUBMB Life; 2019 Sep; 71(9):1313-1321. PubMed ID: 30957389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of in vivo immunomodulatory effects of intravenous and intraperitoneal administration of adipose-tissue mesenchymal stem cells in experimental autoimmune encephalomyelitis (EAE).
    Yousefi F; Ebtekar M; Soleimani M; Soudi S; Hashemi SM
    Int Immunopharmacol; 2013 Nov; 17(3):608-16. PubMed ID: 23973288
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential TLR activation of murine mesenchymal stem cells generates distinct immunomodulatory effects in EAE.
    Vega-Letter AM; Kurte M; Fernández-O'Ryan C; Gauthier-Abeliuk M; Fuenzalida P; Moya-Uribe I; Altamirano C; Figueroa F; Irarrázabal C; Carrión F
    Stem Cell Res Ther; 2016 Oct; 7(1):150. PubMed ID: 27724984
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disparate Effects of Mesenchymal Stem Cells in Experimental Autoimmune Encephalomyelitis and Cuprizone-Induced Demyelination.
    Glenn JD; Smith MD; Kirby LA; Baxi EG; Whartenby KA
    PLoS One; 2015; 10(9):e0139008. PubMed ID: 26407166
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endothelin-1 overexpression exacerbate experimental allergic encephalomyelitis.
    Guo Y; Chung SK; Siu CW; Kwan SC; Ho PW; Yeung PK; Chan KH
    J Neuroimmunol; 2014 Nov; 276(1-2):64-70. PubMed ID: 25205217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesenchymal stem cells ameliorate experimental autoimmune encephalomyelitis inducing T-cell anergy.
    Zappia E; Casazza S; Pedemonte E; Benvenuto F; Bonanni I; Gerdoni E; Giunti D; Ceravolo A; Cazzanti F; Frassoni F; Mancardi G; Uccelli A
    Blood; 2005 Sep; 106(5):1755-61. PubMed ID: 15905186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mesenchymal stem cells (MSC) derived from mice with experimental autoimmune encephalomyelitis (EAE) suppress EAE and have similar biological properties with MSC from healthy donors.
    Kassis I; Petrou P; Halimi M; Karussis D
    Immunol Lett; 2013; 154(1-2):70-6. PubMed ID: 23994102
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic administration of orexin A ameliorates established experimental autoimmune encephalomyelitis by diminishing neuroinflammation.
    Becquet L; Abad C; Leclercq M; Miel C; Jean L; Riou G; Couvineau A; Boyer O; Tan YV
    J Neuroinflammation; 2019 Mar; 16(1):64. PubMed ID: 30894198
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.